Search
for
Sort by
Research 421–450 of 1000+
- 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- 724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata
- Efficacy of modern methods for assessing the severity of alopecia areata
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity
- BH15 The burden of alopecia areata: examining baseline health-related quality of life and clinical assessment tools
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Efficacy of Intralesional Vitamin D in the Treatment of Alopecia Areata Using Dermoscopy before and after Treatment
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Role of platelet rich plasma therapy in the treatment of alopecia areata and atrophic acne scars
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Review of the 2024 American Academy of Dermatology (AAD) Annual Meeting
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Assessment Of the Relation of Serum Adiponectin Level With Alopecia Areata
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Alopecia Areata Treated with Homoeopathic Preparation of Phosphorus: Two Evidence-Based Case Reports
- Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- Is thyroid dysfunction a common cause of telogen effluvium?: A retrospective study
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Growth Factors and Microneedling in Alopecia Areata: A Narrative Review
- PRP versus intralesional triamcinolone for alopecia areata comparative study
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata